Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid

(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid

(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid structure

(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid 

structure
  • CAS No:

    128253-31-6

  • Formula:

    C23H23NO3

  • Chemical Name:

    (2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid

  • Synonyms:

    2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid;Bay X 1005;Bay X1005;Bay-X1005;BAYX-1005;DG-031;Veliflapon;Veliflapon;128253-31-6;Bay-x-1005;Bay X 1005;DG-031;Bay-X1005;BAY 1005;UNII-JXH6X663L0;BAY-X 1005;DG 031;CHEMBL88712;JXH6X663L0;(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid;128253-31-6 (acid);Bayx-1005;Bay X1005;(2R)-cyclopentyl{4-[(quinolin-2-yl)methoxy]phenyl}acetic acid;(R)-2-(4-(Quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid;Veliflapon [USAN:INN];Velifapon;2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid;QY1;Veliflapon (USAN/INN);Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (R)-;MLS006010705;GTPL5148;SCHEMBL1004174;BAY-X-005;DTXSID60155843;ZINC598193;BDBM50052030;MFCD00870329;AKOS024457673;SB19085;NCGC00250411-01;HY-14165;SMR004701678;CS-0003243;BAY-X-1005, >=98% (HPLC);D06664;Q27074919;Cyclopentyl-[4-(quinolin-2-ylmethoxy)-phenyl]-acetic acid;(R)-?-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid;(R)-Cyclopentyl-[4-(quinolin-2-ylmethoxy)-phenyl]-acetic acid;2-(R)-cyclopentyl-2-(4-(2-quinolylmethoxy)phenyl)acetic acid;(r)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid;alpha-Cyclopentyl-4-(2-quinolinylmethoxy)-(R)-benzeneacetic acid;(alphaR)-alpha-Cyclopentyl-4-(2-quinolinylmethoxy)-benzeneacetic acid

Description

Veliflapon is under investigation in clinical trial NCT00353067 (Veliflapon (Dg-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina).

(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid Basic Attributes

361.4 g/mol

361.16779360 g/mol

JXH6X663L0

DTXSID60155843

Characteristics

59.4 Ų

Drug Information

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)|Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)

2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid

Computed Properties

Molecular Weight:361.4
XLogP3:5.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:6
Exact Mass:361.16779360
Monoisotopic Mass:361.16779360
Topological Polar Surface Area:59.4
Heavy Atom Count:27
Complexity:482
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.